Neuraxpharm Vows Swift Appeal Over Pulled EU Tecfidera Generics
CNS Specialist Says Decision Was ‘Rooted In A Highly Disputed Legal Interpretation’
Neuraxpharm has vowed to rapidly challenge a legal decision that has seen generic rivals to Biogen’s Tecfidera (dimethyl fumarate) multiple sclerosis treatment pulled from the market in Europe.
